R1507
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for R1507, covering 2011-09-16 to 2021-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of R1507 in Participants With Recurrent or Refractory Sarcoma [Phase 2]